Skip to main content
. Author manuscript; available in PMC: 2023 Aug 28.
Published in final edited form as: Nat Protoc. 2022 Mar 23;17(5):1266–1305. doi: 10.1038/s41596-022-00681-y

Table 6.

Day 0: E6SFB differentiation medium composition

Components Vendor Cat. no. Stock concentration Final concentration Volume (30 mL)
Essential 6 medium Gibco A1516401 - 98% (v/v) 29.4 mL
Matrigel, growth factor reduced Corning 354230 - 2% (v/v) 600 μL
SB (TGF-β inhibitor) Stemgent 04-0010-05 10 mM 10 μM 30 μL
Recombinant human bFGF PeproTech 100-18B 200 μg/mL 4 ng/mL 0.6 μL
Recombinant human BMP4 PeproTech 120-05 100 μg/mL 5 ng/mL 1.5 μL
Normocin InvivoGen Ant-nr-1 50 mg/mL 100 μg/mL 60 μL